Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Antiproliferation effect of imatinib mesylate on MCF7, T-47D tumorigenic and MCF 10A nontumorigenic breast cell lines via PDGFR-β, PDGF-BB, c-Kit and SCF genes

1 Feb 2017

Abstract excerpt

Recent cancer molecular therapies are targeting main functional molecules to control applicable process of cancer cells. Attractive targets are established by receptor tyrosine kinases, such as platelet-derived growth factor receptors (PDGFRs) and c-Kit as mostly irregular signaling, which is due to either over expression or mutation that is associated with tumorigenesis and cell proliferation. Imatinib mesylate...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chronic Myeloid Leukemia Treatments
Share to Eosinophilic Disorders and Syndromes
Share to Gastrointestinal Tumor Research and Treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 28260860
DOI: 10.2147/dddt.s124102

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 11 closest

Antiproliferation effect of imatinib mesylate on MCF7, T-47D tumorigenic and MCF 10A nontumorigenic breast cell lines via PDGFR-β, PDGF-BB, c-Kit and SCF genesPMID 28260860Read ↗

Imatinib mesylate inhibits Leydig cell tumor growth: evidence for in vitro and in vivo activity.Semantic proximity Read ↗

Effects of imatinib vary with the types of KIT-mutation in gastrointestinal stromal tumor cell lines.Semantic proximity Read ↗

[Effect of tyrosine kinase inhibitor Imatinib mesylate on proliferation, differentiation and apoptosis of Kasumi-1 leukemia cell line].Semantic proximity Read ↗

Ex vivo evaluation of imatinib mesylate for induction of cell death on canine neoplastic mast cells with mutations in c-Kit exon 11 via apoptosis.Semantic proximity Read ↗

Imatinib inhibits various types of activating mutant kit found in gastrointestinal stromal tumors.Semantic proximity Read ↗

C-kit and PDGFRA gene mutations in triple negative breast cancer.Semantic proximity Read ↗

Antitumor activity of S116836, a novel tyrosine kinase inhibitor, against imatinib-resistant FIP1L1-PDGFRα-expressing cells.Semantic proximity Read ↗

Imatinib mesylate inhibits cell growth of malignant peripheral nerve sheath tumors in vitro and in vivo through suppression of PDGFR-β.Semantic proximity Read ↗

Imatinib mesylate (Gleevec) downregulates telomerase activity and inhibits proliferation in telomerase-expressing cell linesSemantic proximity Read ↗

Analysis of gene expression profiles in an imatinib-resistant cell line, KCL22/SR.Semantic proximity Read ↗

Effect of tyrosine kinase inhibition by imatinib mesylate on mast cell tumors in dogs.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.